Antithrombotic treatment in patients with heart failure and associated atrial fibrillation and vascular disease: A nationwide cohort study

Journal of the American College of Cardiology

Volumn 63, Issue 24, 2014, Pages 2689-2698

  Lamberts, Morten ^a   Lip, Gregory Y H ^b   Ruwald, Martin H ^a   Hansen, Morten Lock ^a   Özcan, Cengiz ^a   Kristensen, Søren L ^a   Køber, Lars ^c   Torp Pedersen, Christian ^d   Gislason, Gunnar H ^a,e  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Rigshospitalet   (Denmark)

^d AALBORG UNIVERSITY   (Denmark)

^e UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antithrombotic treatment; atrial fibrillation; coronary artery disease; heart failure; vascular disease

Indexed keywords

ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; CLOPIDOGREL; PHENPROCOUMON; WARFARIN;

AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR RISK; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; PROGNOSIS; RISK REDUCTION; THROMBOEMBOLISM; VASCULAR DISEASE; CHA2DS2 VASC SCORE; FOLLOW UP; HAS BLED SCORE; HOSPITAL PATIENT; INCIDENCE; PREVALENCE; RISK ASSESSMENT; RISK FACTOR; SCORING SYSTEM; TREATMENT OUTCOME;

ANTITHROMBOTIC TREATMENT; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; HEART FAILURE; VASCULAR DISEASE;

AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; COHORT STUDIES; DENMARK; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; REGISTRIES; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASCULAR DISEASES;

EID: 84902593669     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2014.03.039     Document Type: Article

References (41)

1. G.Y. Lip, P. Piotrponikowski, and F. Andreotti et al. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis Thromb Haemost 108 2012 1009 1022
2. G.Y. Lip, and C.R. Gibbs Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm Cochrane Database Syst Rev 4 2001 CD003333
3. B.M. Massie Aspirin use in chronic heart failure: what should we recommend to the practitioner? J Am Coll Cardiol 46 2005 963 966
4. G.Y. Lip, B.J. Wrigley, and R. Pisters Anticoagulation versus placebo for heart failure in sinus rhythm Cochrane Database Syst Rev 6 2012 CD003336
5. C. Patrono, C. Baigent, J. Hirsh, G. Roth American College of Chest Physicians Antiplatelet drugs: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 2008 199S 233S
6. C. Patrono, F. Bachmann, and C. Baigent et al. Expert consensus document on the use of antiplatelet agents. The task force on the use of antiplatelet agents in patients with atherosclerotic cardiovascular disease of the European Society of Cardiology Eur Heart J 25 2004 166 181
7. Warfarin Antiplatelet Vascular Evaluation Trial I, S. Anand, and S. Yusuf et al. Oral anticoagulant and antiplatelet therapy and peripheral arterial disease N Engl J Med 357 2007 217 227
8. J.J. McMurray, S. Adamopoulos, and S.D. Anker et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
9. A.J. Camm, G.Y. Lip, R. De Caterina ESC Committee for Practice Guidelines (CPG) 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: An update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association Eur Heart J 33 2012 2719 2747
10. G.Y. Lip, F. Andreotti, and L. Fauchier et al. Bleeding risk assessment and management in atrial fibrillation patients. Executive Summary of a Position Document from the European Heart Rhythm Association [EHRA], endorsed by the European Society of Cardiology [ESC] Working Group on Thrombosis Thromb Haemost 106 2011 997 1011
11. R. Sorensen, M.L. Hansen, and S.Z. Abildstrom et al. Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data Lancet 374 2009 1967 1974
12. M.L. Hansen, R. Sorensen, and M.T. Clausen et al. Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation Arch Intern Med 170 2010 1433 1441
13. A.L. Gulløv, B.G. Koefoed, and P. Petersen Bleeding during warfarin and aspirin therapy in patients with atrial fibrillation: the AFASAK 2 study. Atrial Fibrillation Aspirin and Anticoagulation Arch Intern Med 159 1999 1322 1328
14. K. Buresly, M.J. Eisenberg, X. Zhang, and L. Pilote Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction Arch Intern Med 165 2005 784 789
15. M. Moscucci, K.A. Fox, and C.P. Cannon et al. Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1815 1823
16. J. Hirsh, J. Dalen, and D.R. Anderson et al. Oral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range Chest 119 (1 Suppl) 2001 8S 21S
17. S. Homma, J.L. Thompson, and P.M. Pullicino et al. Warfarin and aspirin in patients with heart failure and sinus rhythm N Engl J Med 366 2012 1859 1869
18. E. Lynge, J.L. Sandegaard, and M. Rebolj The Danish National Patient Register Scand J Public Health 39 2011 30 33
19. H.W. Kildemoes, H.T. Sorensen, and J. Hallas The Danish National Prescription Registry Scand J Public Health 39 2011 38 41
20. K. Helweg-Larsen The Danish Register of Causes of Death Scand J Public Health 39 2011 26 29
21. G.H. Gislason, J.N. Rasmussen, and S.Z. Abildstrom et al. Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomes Circulation 116 2007 737 744
22. M. Lamberts, J.B. Olesen, and M.H. Ruwald et al. Bleeding after initiation of multiple antithrombotic drugs, including triple therapy, in atrial fibrillation patients following myocardial infarction and coronary intervention: a nationwide cohort study Circulation 126 2012 1185 1193
23. J.B. Olesen, G.Y. Lip, and M.L. Hansen et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
24. J.B. Olesen, G.Y. Lip, and A.L. Kamper et al. Stroke and bleeding in atrial fibrillation with chronic kidney disease N Engl J Med 367 2012 625 635
25. J.B. Olesen, G.Y. Lip, and J. Lindhardsen et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a 'real world' nationwide cohort study Thromb Haemost 106 2011 739 749
26. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). The CONSENSUS Trial Study Group N Engl J Med 316 1987 1429 1435
27. V. Fuster, B.J. Gersh, E.R. Giuliani, A.J. Tajik, R.O. Brandenburg, and R.L. Frye The natural history of idiopathic dilated cardiomyopathy Am J Cardiol 47 1981 525 531
28. D. Conen, C.U. Chae, and R.J. Glynn et al. Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation JAMA 305 2011 2080 2087
29. M. Rivero-Ayerza, W. Scholte Op Reimer, and M. Lenzen et al. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey Eur Heart J 29 2008 1618 1624
30. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2010 263 272
31. M. Davies, F. Hobbs, and R. Davis et al. Prevalence of left-ventricular systolic dysfunction and heart failure in the Echocardiographic Heart of England Screening study: a population based study Lancet 358 2001 439 444
32. T. Kumler, G.H. Gislason, and V. Kirk et al. Accuracy of a heart failure diagnosis in administrative registers Eur J Heart Fail 10 2008 658 660
33. L. Friberg, M. Rosenqvist, and G.Y. Lip Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study Eur Heart J 33 2012 1500 1510
34. R.G. Hart, L.A. Pearce, and M.I. Aguilar Adjusted-dose warfarin versus aspirin for preventing stroke in patients with atrial fibrillation Ann Intern Med 147 2007 590 592
35. R.F. van Es, J.J. Jonker, F.W. Verheugt, J.W. Deckers, and D.E. Grobbee Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial Lancet 360 2002 109 113
36. S.S. Anand, and S. Yusuf Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis JAMA 282 1999 2058 2067
37. L.H. Krarup, G. Boysen, H. Janjua, E. Prescott, and T. Truelsen Validity of stroke diagnoses in a National Register of Patients Neuroepidemiology 28 2007 150 154
38. K.J. Mukamal, J.S. Tolstrup, J. Friberg, G. Jensen, and M. Gronbaek Alcohol consumption and risk of atrial fibrillation in men and women: the Copenhagen City Heart Study Circulation 112 2005 1736 1742
39. M. Madsen, M. Davidsen, S. Rasmussen, S.Z. Abildstrom, and M. Osler The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry J Clin Epidemiol 56 2003 124 130
40. R.S. Freudenberger, A.C. Wilson, J.B. Kostis AFFIRM Investigators and Committees Comparison of rate versus rhythm control for atrial fibrillation in patients with left ventricular dysfunction (from the AFFIRM Study) Am J Cardiol 100 2007 247 252
41. D.G. Wyse, A.L. Waldo, and J.P. DiMarco et al. A comparison of rate control and rhythm control in patients with atrial fibrillation N Engl J Med 347 2002 1825 1833